Antibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinations

Adam, 1989, Pharmacokinetics at ticarcillin/clavulanate in severely burned patients, J Antimicrob Chemother, 24, 121, 10.1093/jac/24.suppl_B.121 Bicknell, 1985, The production and molecular properties of the zinc β-lactamase of Pseudomonas maltophilia IID 1275, Biochem J, 229, 791, 10.1042/bj2290791 Bush, 1989, Classification of β-lactamases: groups 2c, 2d, 2e, 3, and 4, Antimicrob Agents Chemother, 33, 271, 10.1128/AAC.33.3.271 Cartwright, 1984, Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose, Biochem J, 221, 505, 10.1042/bj2210505 Chan, 1987, Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas, Diagn Microbiol Infect Dis, 6, 157, 10.1016/0732-8893(87)90101-5 Chow, 1988, Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiple drug-resistant Pseudomonas maltophilia, Antimicrob Agents Chemother, 32, 782, 10.1128/AAC.32.5.782 Felegie, 1979, Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination, Antimicrob Agents Chemother, 16, 833, 10.1128/AAC.16.6.833 Holmes, 1979, Distribution in clinical material and identification of Pseudomonas maltophilia, J Clin Pathol, 32, 62, 10.1136/jcp.32.1.66 Metchock, 1989, Susceptibility of Pseudomonas (Xanthomonas) maltophilia to antimicrobial agents, Antimicrob News, 6, 35, 10.1016/0738-1751(89)90042-7 Mett, 1988, Outer membrane permeability and β-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants, Rev Infect Dis, 10, 765, 10.1093/clinids/10.4.765 Morrison, 1986, Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital, J Clin Microbiol, 24, 52, 10.1128/JCM.24.1.52-55.1986 Muder, 1987, Infections caused by Pseudomonas maltophilia, Arch Intern Med, 147, 1672, 10.1001/archinte.147.9.1672 National Committee for Clinical Laboratory Standards (NCCLS), 1985, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standards Neu, 1984, Unusual nosocomial infections, Dis-A-Month, 30, 1 Neu, 1989, Resistance of Xanthomonas maltophilia to antibiotics and the effect of β-lactamase inhibitors, Diagn Microbiol Infect Dis, 12, 283, 10.1016/0732-8893(89)90030-8 Nord, 1974, Synergistic effect of combinations of sulphametoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia, Antimicrob Agents Chemother, 6, 521, 10.1128/AAC.6.4.521 Saino, 1982, Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia, Antimicrob Agents Chemother, 22, 564, 10.1128/AAC.22.4.564 Saino, 1984, Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia, Antimicrob Agents Chemother, 25, 362, 10.1128/AAC.25.3.362 Swabb, 1985, Clinical pharmacology of aztreonam in healthy recipients and patients: a review, Rev Infect Dis, 7, 605, 10.1093/clinids/7.Supplement_4.S605 Wheat, 1985, Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia, J Clin Pathol, 38, 1055, 10.1136/jcp.38.9.1055 Yu, 1980, Synergistic interactions in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia, J Infect Dis, 142, 602, 10.1093/infdis/142.4.602 Zuravleff, 1982, Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and review of the literature, Rev Infect Dis, 4, 1236, 10.1093/clinids/4.6.1236